The Joint Stock Company "Rosatom RDS" (part of the State Corporation "Rosatom") presents advanced energy and medical systems and complexes in the Russian and global markets, developed in collaboration with leading scientific and technological enterprises and medical institutions. In particular, in the portfolio of medical projects of the Joint Stock Company "Rosatom RDS" is the nitric oxide therapy device "TIANOX," which has no analogs in the world. The Joint Stock Company "Rosatom RDS" is also developing a range of electric motors with power from 30 kW to 32 MW for nuclear power plants, shipbuilding, and the gas industry, and is creating and promoting electronics and conversion equipment, electrical and polymer materials in the market.